Skip to main content
Roy Baynes, MD, Oncology, New York, NY

Roy D Baynes MD PhD

Hematologic Oncology


Executive Vice President and Chief Medical Officer, Eikon Therapeutics

Join to View Full Profile
  • 450 East 29th StreetNew York, NY 10016

Dr. Baynes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of the Witwatersrand
    University of the WitwatersrandClass of 1978

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 1989 - 2019
  • MO State Medical License
    MO State Medical License 1995 - 2019

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Merck’s KEYTRUDA® (Pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients with Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
    Merck’s KEYTRUDA® (Pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients with Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 ExpressionMarch 17th, 2022
  • Merck’s Keytruda Reduced Risk of Disease Recurrence or Death in Early Lung Cancer Patients by 24%
    Merck’s Keytruda Reduced Risk of Disease Recurrence or Death in Early Lung Cancer Patients by 24%March 17th, 2022
  • Pivotal Phase 3 Data for KEYTRUDA® (Pembrolizumab) in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC) Published in the New England Journal of Medicine
    Pivotal Phase 3 Data for KEYTRUDA® (Pembrolizumab) in High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC) Published in the New England Journal of MedicineFebruary 10th, 2022
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: